Scarica l'app Stockscreener
14.81
1.14%
-0.155
Precedente Chiudi:
$14.97
Aprire:
$14.67
Volume 24 ore:
146.85K
Relative Volume:
0.22
Capitalizzazione di mercato:
$5.25B
Reddito:
$4.89B
Utile/perdita netta:
$-263.00M
Rapporto P/E:
-19.16
EPS:
-0.7734
Flusso di cassa netto:
$-167.84M
1 W Prestazione:
+2.64%
1M Prestazione:
-0.67%
6M Prestazione:
+24.89%
1 anno Prestazione:
-28.74%
Intervallo 1D:
$14.67
$15.17
Intervallo di 1 settimana:
$13.77
$15.30
Portata 52W:
$10.45
$21.08
Bausch Lomb Corp Stock (BLCO) Company Profile
Nome
Bausch Lomb Corp
Settore
Industria
Telefono
908-541-5456
Indirizzo
520 APPLEWOOD CRESCENT, VAUGHAN
Confronta BLCO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
14.81 | 5.35B | 4.89B | -263.00M | -167.84M | -0.7734 |
|
ISRG
Intuitive Surgical Inc
|
435.50 | 156.44B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
183.34 | 53.99B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
270.25 | 39.41B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.21 | 36.63B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
266.11 | 18.78B | 2.96B | 487.70M | 344.00M | 6.6758 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-01 | Iniziato | Goldman | Neutral |
| 2025-05-02 | Reiterato | H.C. Wainwright | Buy |
| 2025-03-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-07-10 | Iniziato | Raymond James | Outperform |
| 2024-05-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-12-12 | Iniziato | Stifel | Hold |
| 2023-10-03 | Ripresa | Evercore ISI | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-09 | Iniziato | Needham | Hold |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-09-12 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-06-24 | Iniziato | Evercore ISI | Outperform |
| 2022-06-06 | Iniziato | Citigroup | Buy |
| 2022-05-31 | Iniziato | Deutsche Bank | Hold |
| 2022-05-31 | Iniziato | Goldman | Neutral |
| 2022-05-31 | Iniziato | Guggenheim | Buy |
| 2022-05-31 | Iniziato | JP Morgan | Neutral |
| 2022-05-31 | Iniziato | Jefferies | Buy |
| 2022-05-31 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Iniziato | Wells Fargo | Overweight |
| 2022-05-11 | Iniziato | Cowen | Outperform |
Mostra tutto
Bausch Lomb Corp Borsa (BLCO) Ultime notizie
What does recent volatility data suggest for Bausch + Lomb Corporation2025 Short Interest & Long-Term Growth Portfolio Plans - newser.com
Contact Lenses Market Trends, Shares, Strategies and Growth Analysis Report (2025-2034) Featuring Alcon Vision, Bausch & Lomb, J&J Vision Care, CooperVision, Essilor International and More - GlobeNewswire Inc.
Earnings call transcript: Bausch + Lomb sees revenue growth in Q2 2025 - Investing.com India
BofA rates Bausch & Lomb ‘underperform’ with lower buyout chances - MSN
Stifel reiterates Buy rating on Bausch & Lomb stock, maintains $12 price target - Investing.com UK
Bausch + Lomb (NYSE:BLCO): Evaluating Valuation After Recent Earnings and Share Price Moves - Yahoo Finance
Analyzing drawdowns of Bausch + Lomb Corporation with statistical toolsMarket Movement Recap & Community Driven Trade Alerts - newser.com
Bausch + Lomb's (BLCO) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Bausch + Lomb Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators - Markets Mojo
Bausch + Lomb (NYSE:BLCO) Stock Price Expected to Rise, Evercore ISI Analyst Says - MarketBeat
What drives Bausch Lomb Corporation stock priceVolume Spike Alerts & Fast Growing Capital Growth - earlytimes.in
Bausch + Lomb Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
Can Bausch + Lomb Corporation (S2L) stock deliver strong annual returnsShare Buyback & Step-by-Step Trade Execution Guides - newser.com
Barclays Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Maintains Target Price $16 - 富途牛牛
Assessing Bausch + Lomb (NYSE:BLCO) Valuation as Goldman Sachs Brings New Spotlight to Ophthalmology Growth Prospects - simplywall.st
Bausch + Lomb (NYSE:BLCO) Coverage Initiated at The Goldman Sachs Group - MarketBeat
Is Bausch + Lomb Corporation (S2L) stock a momentum leaderMarket Risk Report & Consistent Income Trade Recommendations - newser.com
Applying Elliott Wave Theory to Bausch + Lomb CorporationQuarterly Market Review & Comprehensive Market Scan Reports - newser.com
Why Bausch + Lomb Corporation stock is upgraded to buy2025 Breakouts & Breakdowns & Weekly Market Pulse Updates - newser.com
Goldman Sachs Initiates Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Announces Target Price $16 - 富途牛牛
Goldman Sachs initiates Bausch & Lomb stock with Neutral rating By Investing.com - Investing.com South Africa
Goldman Sachs initiates Bausch & Lomb stock with Neutral rating - Investing.com
Is Zeal Aqua Limited a Smart Pick for Retirement PortfoliosEx-Dividend Date Alerts & Analyze Your Portfolio Risk in Seconds - earlytimes.in
Bausch + Lomb Will Release Third-Quarter 2025 Financial Results on Oct. 29 and Hold Investor Day on Nov. 13 - BioSpace
Is Bausch + Lomb Corporation stock positioned for digital transformationMarket Growth Review & AI Driven Stock Reports - newser.com
Global Eye Health Leader Bausch + Lomb Announces Q3 Earnings Date and Strategic Investor Day Pipeline Review - Stock Titan
Will Bausch + Lomb Corporation stock benefit from Fed rate cutsBuy Signal & Real-Time Volume Surge Alerts - newser.com
Why Bausch + Lomb Corporation stock could be next leaderJuly 2025 Catalysts & Verified Momentum Stock Ideas - newser.com
Bausch + Lomb, Enovis, and Haemonetics Shares Plummet, What You Need To Know - Yahoo Finance
Applying chart zones and confluence areas to Bausch + Lomb CorporationIndex Update & Safe Swing Trade Setup Alerts - newser.com
Bausch + Lomb: There Are Better Opportunities Out There (Rating Downgrade) - Seeking Alpha
Trade Recap: Why is Bausch Lomb Corporation stock going upJuly 2025 Market Mood & Safe Capital Growth Tips - خودرو بانک
Goldman Sachs Group Inc. Grows Position in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb Corporation $BLCO Shares Sold by Dynamic Technology Lab Private Ltd - MarketBeat
Bausch + Lomb Corporation (NYSE:BLCO) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Vident Advisory LLC Makes New Investment in Bausch + Lomb Corporation $BLCO - MarketBeat
Aug Shorts: Is Bausch Lomb Corporation exposed to currency risksEarnings Recap Report & Risk Adjusted Buy and Sell Alerts - خودرو بانک
Clearline Capital LP Acquires 247,149 Shares of Bausch + Lomb Corporation $BLCO - MarketBeat
Cubist Systematic Strategies LLC Takes $2.12 Million Position in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb (NYSE:BLCO): Valuation Perspective After New Clinical Data and ASANA Lens Launch - Yahoo Finance
Revolutionary Full Range Vision Lens: Bausch + Lomb's enVista Envy Succeeds in 501-Patient Trial - Stock Titan
Bausch + Lomb (BLCO) Study Shows XIIDRA Eye Drops Improve Comfort For Contact Lens Wearers - Sahm
Bausch Lomb Corp Azioni (BLCO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
5.05%
0.53%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):